Dr. James Gulley
Location: Botterell Hall, Room B147
Dr. James Gulley M.D. , PhD.
Genitourinary Malignancies Branch
Head, Immunotherapy Section
Director, Medical Oncology Service, CCR Office of the Clinical Director
Immunotherapy has made a big impact in clinical oncology in the last 5 years however this clinical activity is only seen in the minority of tumors that already are recognized by the immune system (either due to neoantigens or viral antigens) and have an active but stalled immune response. Several techniques are showing promise in combination with immune checkpoint inhibition that may broaden the activity of immunotherapy to the majority of tumors that aren't recognized by the patient's immune system. Dr. Gulley will discuss some of these approaches his group is testing in the clinic and share emerging data as well as techniques to evaluate the impact of immunotherapy on the tumor microenvironment.
Wednesday, May 9th, 2018
1:00 - 2:00pm
Botterell Hall, Room B147